ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05145	Toxoplasmosis	3/11	126/7206	0.000777356296554
ko05321	Inflammatory bowel disease (IBD)	2/11	56/7206	0.00311921351001
ko05140	Leishmaniasis	2/11	75/7206	0.00553238862459
ko04658	Th1 and Th2 cell differentiation	2/11	96/7206	0.00893339902767
ko04659	Th17 cell differentiation	2/11	106/7206	0.0108118323453
ko05215	Prostate cancer	2/11	111/7206	0.0118116614664
ko04931	Insulin resistance	2/11	137/7206	0.0176380189173
ko04919	Thyroid hormone signaling pathway	2/11	143/7206	0.0191268980214
ko05160	Hepatitis C	2/11	153/7206	0.0217239319139
ko04621	NOD-like receptor signaling pathway	2/11	157/7206	0.0228024252113
ko04152	AMPK signaling pathway	2/11	161/7206	0.0239032011772
ko05164	Influenza A	2/11	167/7206	0.0255955802779
ko05310	Asthma	1/11	17/7206	0.0256642497537
ko05332	Graft-versus-host disease	1/11	18/7206	0.027155095943
ko05161	Hepatitis B	2/11	173/7206	0.027336649755
ko04217	Necroptosis	2/11	178/7206	0.0288241176448
ko05168	Herpes simplex infection	2/11	182/7206	0.0300376798073
ko04150	mTOR signaling pathway	2/11	184/7206	0.030652237813
ko05152	Tuberculosis	2/11	187/7206	0.0315837088845
ko05330	Allograft rejection	1/11	24/7206	0.0360567082738
ko00511	Other glycan degradation	1/11	26/7206	0.0390074165086
ko05320	Autoimmune thyroid disease	1/11	29/7206	0.0434180849463
ko04940	Type I diabetes mellitus	1/11	32/7206	0.0478103423824